HemaSphere (Aug 2023)

S190: FIRST RESULTS FROM THE REDIRECTT-1 STUDY WITH TECLISTAMAB (TEC) + TALQUETAMAB (TAL) SIMULTANEOUSLY TARGETING BCMA AND GPRC5D IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

  • Maria-Victoria Mateos,
  • Daniel Morillo,
  • Moshe Gatt,
  • Michael Sebag,
  • Kihyun Kim,
  • Chang-Ki Min,
  • Albert Oriol,
  • Enrique Ocio,
  • Sung-Soo Yoon,
  • Yael Cohen,
  • Michael Chu,
  • Paula Rodríguez-Otero,
  • Irit Avivi,
  • Yue Guo,
  • Maria Krevvata,
  • Michelle Peterson,
  • Melissa Beelen,
  • Jill Vanak,
  • Arnob Banerjee,
  • Hila Magen

DOI
https://doi.org/10.1097/01.HS9.0000967672.15362.d7
Journal volume & issue
Vol. 7
p. e15362d7

Abstract

Read online

No abstracts available.